HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Basic fibroblast growth factor impact on retinoblastoma progression and survival.

AbstractPURPOSE:
Chemotherapy resistance is a problem in the treatment of advanced retinoblastoma (RB). Since basic fibroblast growth factor (bFGF) is a survival factor for neural precursor cells, bFGF was evaluated as a growth and chemoresistance factor in RB.
METHODS:
bFGF expression was analyzed in the LH-betaTag transgenic mouse model of RB and human RB cell lines by immunofluorescence, RT-PCR, and Western blot. Proliferation and apoptosis (TUNEL) assays were performed.
RESULTS:
bFGF levels significantly increased during tumorigenesis in transgenic RB, as a function of tumor status (P = 0.005). PCR and confocal microscopy confirmed that the human cell lines and primary tumors expressed bFGF. bFGF was localized to vascular and tumor cells and rarely to glial cells. Exogenous 18-kDa bFGF induced proliferation in two RB cell lines (WERI and Y79). Western blot analysis demonstrated 34-, 22-, and 18-kDa isoforms in transgenic RB and both cell lines. In TUNEL assays, chemoresistance to carboplatin-induced apoptosis was observed in the Y79 line, which expressed a higher ratio of high (34 kDa)- to low-molecular-weight bFGF isoforms, compared with the WERI line. Similar to other bFGF tumor studies, exogenous low-molecular-weight (18 kDa) bFGF (1 ng) significantly enhanced carboplatin-induced apoptosis in the more chemosensitive WERI, but not the chemoresistant Y79 line.
CONCLUSIONS:
RB tumors produce significant amounts of bFGF, and the differential production and response to isoforms of bFGF may have implications for invasive tumor growth and chemoresistance.
AuthorsColleen M Cebulla, Maria-Elena Jockovich, Yolanda Piña, Hinda Boutrid, Armando Alegret, Amy Kulak, Abigail S Hackam, Sanjoy K Bhattacharya, William J Feuer, Timothy G Murray
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 49 Issue 12 Pg. 5215-21 (Dec 2008) ISSN: 1552-5783 [Electronic] United States
PMID18614803 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antineoplastic Agents
  • Fibroblast Growth Factor 2
  • Carboplatin
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Carboplatin (pharmacology)
  • Cell Proliferation (drug effects)
  • Disease Models, Animal
  • Disease Progression
  • Drug Resistance, Neoplasm
  • Fibroblast Growth Factor 2 (metabolism, pharmacology)
  • Fluorescent Antibody Technique, Indirect
  • Gene Expression Regulation, Neoplastic (physiology)
  • Humans
  • In Situ Nick-End Labeling
  • Mice
  • Mice, Transgenic
  • Microscopy, Confocal
  • Retinal Neoplasms (drug therapy, metabolism, mortality)
  • Retinoblastoma (drug therapy, metabolism, mortality)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Rate
  • Tumor Cells, Cultured (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: